ImaCor Receives 510(k) Clearance for Probe

ImaCor has received 510(k) clearance from the FDA to market its ClariTEE probe, a miniaturized transesophageal echocardiography probe used for monitoring cardiac function.

Designed for use in intensive care units, the minimally invasive device allows physicians to see cardiac size and function and assess changes as pharmacologic interventions are made, ImaCor said.

The single-use device can remain inside a patient for up to 72 hours, allowing periodic assessments of the preload and left ventricular systolic function over time.